ArticleProceedings of the National Academy of Sciences of the United States of America2019

Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease.

Ferah Yildirim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.